ASP Isotopes Inc. Files Q1 2025 10-Q
Ticker: ASPI · Form: 10-Q · Filed: May 20, 2025 · CIK: 1921865
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
ASP Isotopes Q1 2025 10-Q filed. Financials updated.
AI Summary
ASP Isotopes Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and business operations, including references to products, motor vehicle and equipment loans, and nuclear fuels. The company's fiscal year ends on December 31st, and its principal executive offices are located in Washington, D.C.
Why It Matters
This filing provides investors and stakeholders with an update on ASP Isotopes Inc.'s financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — The filing is a standard quarterly report and does not contain immediate red flags or significant negative developments.
Key Players & Entities
- ASP Isotopes Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250520 (date) — Filing date
- Washington, D.C. (location) — Location of principal executive offices
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 20, 2025.
What is the fiscal year end for ASP Isotopes Inc.?
ASP Isotopes Inc.'s fiscal year ends on December 31st.
Where are ASP Isotopes Inc.'s principal executive offices located?
ASP Isotopes Inc.'s principal executive offices are located at 601 Pennsylvania Avenue NW, South Building, Suite 900, Washington, D.C. 20004.
What are some of the product categories mentioned in the filing?
The filing mentions product categories such as motor vehicle and equipment loans, tools, machinery and equipment, and nuclear fuels.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 20, 2025 regarding ASP Isotopes Inc. (ASPI).